Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-10-040611
Filing Date
2010-04-29
Accepted
2010-04-29 16:15:08
Documents
5
Period of Report
2010-06-15
Effectiveness Date
2010-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A b79862def14a.htm DEF 14A 480083
3 GRAPHIC b79862b7986201.gif GRAPHIC 1686
4 GRAPHIC b79862b7986204.gif GRAPHIC 3063
5 GRAPHIC b79862b7986205.gif GRAPHIC 9092
6 filename6.htm CORRESP 4313
  Complete submission text file 0000950123-10-040611.txt   505099
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31918 | Film No.: 10781911
SIC: 2836 Biological Products, (No Diagnostic Substances)